Drugs / FTC/RPV/TAF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02345252 | Jan 2015 → Jun 2016 | HIV infectious disease | Gilead Sciences | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FTC/RPV/TAF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02345252 ↗ |